Consolidated Statements of Cash Flows - USD ($) $ in Millions	6 Months Ended
	Jul. 31, 2021	Aug. 01, 2020
Operating activities
Net earnings	$ 3,914	$ 1,974
Adjustments to reconcile net earnings to cash provided by operating activities:
Depreciation and amortization	1,300	1,245
Share-based compensation expense	138	104
Deferred income taxes	143	(12)
Gain on Dermstore sale	(335)	0
Noncash losses / (gains) and other, net	7	86
Changes in operating accounts:
Inventory	(606)	116
Other assets	3	(14)
Accounts payable	(311)	795
Accrued and other liabilities	(831)	822
Cash provided by operating activities	3,422	5,116
Investing activities
Expenditures for property and equipment	(1,338)	(1,414)
Proceeds from disposal of property and equipment	15	10
Proceeds from Dermstore sale	356	0
Other investments	(5)	2
Cash required for investing activities	(972)	(1,402)
Financing activities
Additions to long-term debt	0	2,480
Reductions of long-term debt	(72)	(126)
Dividends paid	(676)	(662)
Repurchase of stock	(2,850)	(706)
Stock option exercises	5	7
Cash (required for) / provided by financing activities	(3,593)	993
Net (decrease) / increase in cash and cash equivalents	(1,143)	4,707
Cash and cash equivalents at beginning of period	8,511	2,577
Cash and cash equivalents at end of period	7,368	7,284
Supplemental information
Leased assets obtained in exchange for new finance lease liabilities	182	246
Leased assets obtained in exchange for new operating lease liabilities	$ 386	$ 142